# SBEVW (Endovia Health Sciences, Inc.) - SEC EDGAR Financial Statements

> Endovia Health Sciences, Inc. reported $32K in revenue and a net loss of $17.28M for the trailing twelve months ended June 30, 2026 (down 90.9% year over year), with a 79.0% gross margin and a -42092.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/SBEVW
- Markdown: https://convexityos.com/fundamentals/SBEVW.md
- SEC CIK: 0001553788
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001553788&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $32K | -90.9% YoY |
| Operating Income | TTM | -$13.51M | -42092.3% margin |
| Net Income | TTM | -$17.28M | -53856.5% net margin |
| Diluted EPS | TTM | -$5.64 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2026 | $243K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $73K | $801K | $18.85M | $18.09M | $11.32M | $2.98M | $20K | $1.31M | $895K | $1.01M |
| Cost of Revenue | -- | $3.80M | $13.28M | $12.17M | $7.40M | $1.94M | $246K | $605K | $440K | $485K |
| **Gross Profit** | $17K | -$120K | $5.57M | $5.92M | $3.92M | $364K | -$225K | $704K | $455K | $527K |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | $204K | $194K | $163K | $136K |
| Total Operating Expenses | $14.20M | $9.78M | $20.86M | $27.31M | $33.00M | $18.03M | $4.26M | $637K | $612K | $577K |
| **Operating Income** | -$14.19M | -$9.90M | -$15.29M | -$21.39M | -$29.08M | -$17.66M | -$4.49M | $67K | -$157K | -$50K |
| **EBITDA** | -$14.18M | -$9.50M | -$14.74M | -$20.46M | -$28.97M | -$17.55M | -$4.48M | $130K | -$85K | $5.8K |
| Interest Income | -- | $2.0K | $2.6K | $6.1K | $643 | $8 | $132 | $0 | -- | -- |
| Interest Expense | $2.52M | $3.70M | $1.86M | $251K | $443K | -- | $8.4K | $5.7K | $4.5K | $4.7K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$25.23M | -$23.76M | -$21.00M | -$21.69M | -$29.05M | -$28.67M | -$5.14M | $68K | -$148K | -$49K |
| Basic EPS | -$11.97 | -$17.68 | -- | -- | -$1.02 | -$1.06 | -$0.04 | $0.01 | -$0.01 | $0.00 |
| **Diluted EPS** | -$11.97 | -$17.68 | -- | -- | -$1.02 | -$1.06 | -$0.04 | $0.01 | -$0.01 | $0.00 |
| Basic Shares Outstanding | 2.2M | 1.3M | 1.1M | 37.4M | -- | 55.6M | 11.6M | 11.4M | 11.3M | 10.5M |
| Diluted Shares Outstanding | 2.2M | 1.3M | 1.1M | 37.4M | 28.9M | 18.5M | 11.9M | 11.4M | 11.3M | 10.5M |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $4.2K | -$365K | $393K | -$23K | $69K | -$2.77M | $982K |
| Cost of Revenue | -- | -- | -- | $0 | $0 | $469K | $930K | $691K |
| **Gross Profit** | $0 | $1.8K | $47K | -$24K | -$32K | $26K | -$819K | $291K |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | $283K |
| Total Operating Expenses | $2.01M | $981K | $1.02M | $9.54M | $1.50M | $1.68M | -$529K | $2.96M |
| **Operating Income** | -$2.01M | -$979K | -$976K | -$9.54M | -$1.50M | -$1.66M | -$290K | -$2.67M |
| **EBITDA** | -$2.00M | -$977K | -$1.08M | -$9.44M | -$1.50M | -$1.66M | -$293K | -$2.53M |
| Interest Income | -- | -- | -- | -- | -- | -- | $420 | $736 |
| Interest Expense | $231K | $889K | $941K | $320K | $625K | $637K | $1.66M | $890K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$2.05M | -$2.14M | -$3.21M | -$9.89M | -$8.49M | -$3.65M | -$9.04M | -$4.72M |
| Basic EPS | -- | -$0.47 | -- | -- | -- | -$1.97 | -- | -- |
| **Diluted EPS** | -- | -$0.47 | -- | -- | -- | -$1.97 | -- | -- |
| Basic Shares Outstanding | 3.1M | 4.6M | -- | 2.2M | 475.0K | 1.9M | -- | 1.3M |
| Diluted Shares Outstanding | 3.1M | 4.6M | -- | 2.2M | 475.0K | 1.9M | -- | 1.3M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $281K | $14K | $380K | $4.43M | $4.18M | $380K | $43K | $938K | $18K | $62K |
| **Cash & Short-Term Investments** | $281K | $14K | $380K | $4.43M | $4.18M | $380K | $43K | $938K | $18K | $62K |
| Accounts Receivable, Net | $16K | $192K | $891K | $1.81M | $1.11M | $485K | $11K | $301K | $151K | $206K |
| Inventory | $34K | $319K | $2.25M | $3.72M | $1.92M | $798K | $304K | $42K | -- | -- |
| **Total Current Assets** | $632K | $1.90M | $3.98M | $10.66M | $8.34M | $2.24M | $371K | $350K | $194K | $293K |
| Property, Plant & Equipment, Net | $13K | $22K | $350K | $490K | $570K | $681K | $38K | $59K | $47K | $62K |
| Goodwill | -- | -- | $257K | $257K | $257K | $5.67M | -- | -- | -- | -- |
| Intangible Assets | -- | -- | $4.46M | $4.85M | $5.60M | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $334K | $855K | $5.92M | $6.65M | $8.04M | $6.98M | $235K | $59K | $47K | $62K |
| **Total Assets** | $966K | $2.76M | $9.90M | $17.30M | $16.39M | $9.23M | $605K | $408K | $241K | $355K |
| Accounts Payable | $4.81M | $3.59M | $4.44M | $3.38M | $1.91M | $1.52M | $704K | $331K | $226K | $209K |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $6.3K | $16K | $23K | $22K |
| **Total Current Liabilities** | $16.26M | $19.37M | $14.75M | $4.97M | $6.48M | $5.42M | $10.28M | $405K | $300K | $290K |
| Long-Term Debt | $3.4K | $1.97M | $458K | $2.54M | $0 | $1.24M | $2.1K | $5.5K | $14K | $25K |
| **Total Non-Current Liabilities** | $6.4K | $2.02M | $754K | $3.02M | $1.03M | $3.91M | $82K | $5.5K | $14K | $25K |
| **Total Liabilities** | $16.27M | $21.39M | $15.50M | $7.98M | $7.51M | $9.33M | $10.36M | $411K | $314K | $316K |
| **Total Debt (incl. Leases)** | $57K | $2.33M | $1.02M | $3.29M | $1.03M | $1.32M | $27K | $22K | $37K | $47K |
| Common Stock | $749 | $1.7K | $1.1K | $41K | $34K | $21K | $44K | $246K | $244K | $209K |
| Retained Earnings | -$181.9M | -$155.8M | -$133.3M | -$112.3M | -$90.64M | -$61.59M | -$31.85M | -$248K | -$316K | -$169K |
| Accumulated Other Comp. Income | $34K | $81K | -$17K | -$20K | $0 | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -$15.30M | -$18.63M | -$5.61M | $9.32M | $8.87M | -$9.35M | -$9.76M | -$7.83M | -$73K | $40K |
| Total Equity | -$15.30M | -$18.63M | -$5.61M | $9.32M | $8.87M | -$9.35M | -$9.76M | -$7.83M | -$73K | $40K |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $243K | $381K | $281K | $266K | $17K | -- | $14K | -- |
| **Cash & Short-Term Investments** | $243K | $381K | $281K | $266K | $17K | -- | $14K | -- |
| Accounts Receivable, Net | $14K | $20K | $16K | $140K | $141K | $173K | $192K | $595K |
| Inventory | $55K | $55K | $34K | $855K | $855K | $861K | $319K | $1.34M |
| **Total Current Assets** | $900K | $709K | $632K | $1.97M | $1.61M | $1.69M | $1.90M | $3.04M |
| Property, Plant & Equipment, Net | -- | $11K | $13K | $94K | $131K | $168K | $22K | $242K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $257K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $4.17M |
| **Total Non-Current Assets** | $176K | $61K | $334K | $20.52M | $20.63M | $814K | $855K | $5.32M |
| **Total Assets** | $1.08M | $770K | $966K | $22.49M | $22.24M | $2.51M | $2.76M | $8.36M |
| Accounts Payable | $4.09M | $4.63M | $4.81M | $6.75M | $7.04M | $6.32M | $3.59M | $5.58M |
| **Total Current Liabilities** | $16.83M | $16.97M | $16.26M | $15.64M | $13.45M | $20.42M | $19.37M | $17.78M |
| Long-Term Debt | -- | $857 | $3.4K | $58K | $53K | $2.08M | $1.97M | $1.32M |
| **Total Non-Current Liabilities** | $0 | $857 | $6.4K | $70K | $73K | $2.12M | $2.02M | $1.41M |
| **Total Liabilities** | $16.83M | $16.97M | $16.27M | $15.71M | $13.52M | $22.54M | $21.39M | $19.19M |
| **Total Debt (incl. Leases)** | -- | $38K | $57K | $191K | $263K | $2.37M | $2.33M | $1.69M |
| Common Stock | $4.1K | $8.4K | $749 | $2.4K | $1.9K | $1.9K | $1.7K | $61K |
| Retained Earnings | -$186.8M | -$184.4M | -$181.9M | -$178.3M | -$168.0M | -$159.5M | -$155.8M | -$146.8M |
| Accumulated Other Comp. Income | $13K | $11K | $34K | $34K | $35K | $34K | $81K | $61K |
| **Total Stockholders' Equity** | -$15.75M | -$16.20M | -$15.30M | $6.78M | $8.72M | -$20.03M | -$18.63M | -$10.83M |
| Total Equity | -$15.75M | -$16.20M | -$15.30M | $6.78M | -$11.28M | -$20.03M | -$18.63M | -$10.83M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$25.28M | -$23.76M | -$21.00M | -$21.71M | -$29.05M | $28.67M | -$5.14M | $68K | -$148K | -$49K |
| Depreciation & Amortization | $9.3K | $402K | $546K | $936K | $112K | $113K | $9.3K | $63K | $72K | $56K |
| Stock-Based Compensation | $8.62M | $2.36M | $1.17M | $7.41M | $3.97M | $2.33M | $1.62M | $0 | -- | -- |
| Change in Receivables | $176K | $335K | $921K | -$698K | -$630K | -$385K | -$11K | -$150K | -$55K | $39K |
| Change in Inventory | $286K | $596K | $1.47M | -$1.80M | -$1.13M | -$220K | -$27K | -$16K | -$22 | $3.6K |
| Change in Payables | -- | -- | -- | -- | -- | -- | $23K | $105K | $17K | $74K |
| **Operating Cash Flow** | -$4.82M | -$7.30M | -$10.19M | -$14.04M | -$14.70M | -$21.32M | -$2.66M | $62K | -$18K | $32K |
| Capital Expenditure | -- | -$3.2K | -$14K | -$103K | $0 | -$91K | -$13K | -$76K | -$58K | -$58K |
| **Free Cash Flow** | -- | -$7.31M | -$10.20M | -$14.14M | -$14.70M | -$21.41M | -$2.67M | -$13K | -$76K | -$26K |
| Acquisitions, Net | -- | -- | -- | -- | -- | -$500K | -- | -- | -- | -- |
| Purchases of Investments | -- | -- | -- | -- | -- | -$250K | -- | -- | -- | -- |
| **Investing Cash Flow** | -- | -$3.2K | -$14K | -$103K | $0 | -$769K | -$13K | -$68K | -$42K | -$52K |
| Common Stock Issued | $1.30M | -- | $0 | $11.43M | $19.63M | $20.18M | $1.57M | $2.0K | $35K | $90K |
| **Financing Cash Flow** | $5.10M | $7.54M | $6.15M | $14.45M | $19.01M | $22.49M | $1.78M | -$5.8K | $16K | $74K |
| **Net Change in Cash** | $268K | -$153K | -$4.05M | $250K | $3.80M | $337K | -$895K | -- | -- | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$6.64M | $2.50M | -$3.21M | -$9.89M | -$8.49M | -$3.65M | -$9.04M | -$4.72M |
| Depreciation & Amortization | $8.3K | $2.3K | -$102K | $106K | $2.3K | $2.3K | -$3.7K | $135K |
| Stock-Based Compensation | $1.11M | $177K | $677K | $7.75M | $54K | $136K | $271K | $187K |
| Change in Receivables | $6.0K | -$4.6K | -$81K | $109K | $32K | $116K | $39K | $74K |
| Change in Inventory | $0 | -$21K | $248K | -$4.3K | $14K | $28K | -$315K | -$36K |
| **Operating Cash Flow** | -$1.09M | -$930K | -$991K | -$2.47M | -$551K | -$808K | -$920K | -$2.65M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | $0 | -- |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -$920K | -- |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | $0 | -$4.7K |
| Common Stock Issued | $1.58M | $1.40M | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $1.16M | $1.05M | $978K | $2.67M | $696K | $756K | $1.16M | $3.01M |
| **Net Change in Cash** | -$138K | $100K | $17K | $248K | $17K | -$15K | -$230K | $449K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 23.1% | -15.0% | 29.5% | 32.7% | 34.6% | 12.2% | -1104.2% | 53.8% | 50.8% | 52.1% |
| **Operating Margin** | -19415.6% | -1235.6% | -81.1% | -118.3% | -257.0% | -593.5% | -22009.4% | 5.1% | -17.6% | -4.9% |
| **Net Profit Margin** | -34537.0% | -2964.9% | -111.4% | -119.9% | -256.7% | -963.5% | -25191.2% | 5.2% | -16.5% | -4.8% |
| Return on Equity (ROE) | -- | -- | -- | -232.7% | -327.4% | -- | -- | -- | -- | -123.1% |
| Return on Assets (ROA) | -2613.1% | -861.0% | -212.2% | -125.3% | -177.3% | -310.8% | -848.4% | 16.7% | -61.2% | -13.7% |
| Current Ratio | 0.04x | 0.10x | 0.27x | 2.15x | 1.29x | 0.41x | 0.04x | 0.86x | 0.65x | 1.01x |
| Quick Ratio | 0.04x | 0.08x | 0.12x | 1.40x | 0.99x | 0.27x | 0.01x | 0.76x | 0.56x | 0.92x |
| Debt to Equity | -- | -- | -- | 0.35x | 0.12x | -- | -- | -- | -- | 1.19x |
| **Revenue Growth (YoY)** | -90.9% | -95.7% | +4.2% | +59.8% | +280.2% | +14497.2% | -98.4% | +46.2% | -11.6% | +12.8% |
| Gross Profit Growth (YoY) | -- | -102.2% | -5.9% | +51.1% | +977.5% | -- | -132.0% | +54.7% | -13.7% | +12.1% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -6829.7% | -- | -- | -364.6% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -7629.7% | -- | -- | -355.0% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -500.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -4360.7% | -- | -154.8% | +145.6% |
| 5Y Revenue / Share Growth | -37.3% | +34067.9% | +15347.6% | +508.8% | -- | -40.2% | -97.1% | +132.3% | -- | -- |
| 10Y Revenue / Share Growth | -62.5% | +883.5% | +35784.6% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -330484.6% | -- | -- | -27092.6% | -- | -- | -- | -- |
| 10Y Net Income / Share Growth | -606565.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 79.0% | -78.3% | 23.1% | -- | -- | -- | -15.0% | 22.9% |
| **Operating Margin** | -42092.3% | -149724.2% | -18724.7% | -- | -- | -- | -1235.6% | -206.1% |
| **Net Profit Margin** | -53856.5% | -273155.8% | -34537.0% | -- | -- | -- | -2964.9% | -331.0% |
| Return on Equity (ROE) | -- | -- | -- | -458.4% | -297.1% | -- | -- | -- |
| Return on Assets (ROA) | -1605.7% | -3080.8% | -2613.1% | -138.2% | -116.5% | -906.2% | -861.0% | -247.6% |
| Current Ratio | 0.05x | 0.04x | 0.04x | 0.13x | 0.12x | 0.08x | 0.10x | 0.17x |
| Quick Ratio | 0.05x | 0.04x | 0.04x | 0.07x | 0.06x | 0.04x | 0.08x | 0.10x |
| Debt to Equity | -- | -- | -- | 0.03x | 0.03x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -93.8% | -- | -60.0% | -102.2% | -95.5% | -203.0% | -80.9% |
| Gross Profit Growth (YoY) | -- | -92.8% | -- | -108.2% | -113.2% | -84.4% | -211.7% | -77.6% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
